Skip to content
10-Q

Quarterly Report

TREVI THERAPEUTICS, INC. TRVI

0001193125-25-280166

← back to feed
Filed
Nov 13, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2025 · Oct 31, 2025 128.23M sh
Shares Diluted Q3 2025 · Sep 30, 2025 145.1M sh
Shares Diluted Q3 2025 · Sep 30, 2025 131.12M sh
Shares Diluted Q3 2025 · Sep 30, 2024 101.28M sh
Shares Diluted Q3 2025 · Sep 30, 2024 100.62M sh
Capex Q3 2025 · Sep 30, 2025 $12K
Capex Q3 2025 · Sep 30, 2024 $28K
Operating Cash Flow Q3 2025 · Sep 30, 2025 −$34.46M
Operating Cash Flow Q3 2025 · Sep 30, 2024 −$28.71M
Cash And Equivalents Q3 2025 · Sep 30, 2025 $56.87M
Cash And Equivalents Q3 2025 · Dec 31, 2024 $34.1M
Stockholders Equity Q3 2025 · Sep 30, 2025 $189.79M
Stockholders Equity Q3 2025 · Jun 30, 2025 $198.49M
Stockholders Equity Q3 2025 · Dec 31, 2024 $99.64M
Stockholders Equity Q3 2025 · Sep 30, 2024 $58.97M
Stockholders Equity Q3 2025 · Jun 30, 2024 $66.17M
Stockholders Equity Q3 2025 · Dec 31, 2023 $82.55M
Current Liabilities Q3 2025 · Sep 30, 2025 $9.04M
Current Liabilities Q3 2025 · Dec 31, 2024 $10.51M
Total Liabilities Q3 2025 · Sep 30, 2025 $9.57M
Total Liabilities Q3 2025 · Dec 31, 2024 $11.26M
Current Assets Q3 2025 · Sep 30, 2025 $198.3M
Current Assets Q3 2025 · Dec 31, 2024 $109.43M
Total Assets Q3 2025 · Sep 30, 2025 $199.36M
Total Assets Q3 2025 · Dec 31, 2024 $110.9M
Eps Diluted Q3 2025 · Sep 30, 2025 −$0.08
Eps Diluted Q3 2025 · Sep 30, 2025 −$0.26
Eps Diluted Q3 2025 · Sep 30, 2024 −$0.13
Eps Diluted Q3 2025 · Sep 30, 2024 −$0.36
Eps Basic Q3 2025 · Sep 30, 2025 −$0.08
Eps Basic Q3 2025 · Sep 30, 2025 −$0.26
Eps Basic Q3 2025 · Sep 30, 2024 −$0.13
Eps Basic Q3 2025 · Sep 30, 2024 −$0.36
Sga Expense Q3 2025 · Sep 30, 2025 $3.83M
Sga Expense Q3 2025 · Sep 30, 2025 $11.82M
Sga Expense Q3 2025 · Sep 30, 2024 $2.86M
Sga Expense Q3 2025 · Sep 30, 2024 $9.23M
Rd Expense Q3 2025 · Sep 30, 2025 $10.09M
Rd Expense Q3 2025 · Sep 30, 2025 $27.29M
Rd Expense Q3 2025 · Sep 30, 2024 $11.22M
Rd Expense Q3 2025 · Sep 30, 2024 $30.05M
Net Income Q3 2025 · Sep 30, 2025 −$11.8M
Net Income Q3 2025 · Sep 30, 2025 −$34.44M
Net Income Q3 2025 · Sep 30, 2024 −$13.24M
Net Income Q3 2025 · Sep 30, 2024 −$36.5M
Operating Income Q3 2025 · Sep 30, 2025 −$13.92M
Operating Income Q3 2025 · Sep 30, 2025 −$39.11M
Operating Income Q3 2025 · Sep 30, 2024 −$14.09M
Operating Income Q3 2025 · Sep 30, 2024 −$39.28M